Compliance Assurance & Innovation Empowerment | Wuhan Jinglong Pet Oral Dispersible Films Debut at the Global Pet Expo in Orlando, USA, Winning Hearts of Furry Friends

From March 25 to 27, 2026, Wuhan Jinglong Biotechnology Co., Ltd., a company specializing in the R&D, production and contract manufacturing of pet oral dispersible films, stepped onto the international stage for the first time, showcasing its core pet oral dispersible film products at Global Pet Expo in Orlando, USA.

Leveraging this authoritative North American platform, the company earned high recognition from overseas merchants and consumers for its compliant production standards, innovative dosage forms and excellent user experience, marking a crucial step forward in its global brand layout.

Global Pet Expo in Orlando, USA is a highly influential professional pet industry event in North America with strict exhibition standards, bringing together high-quality global pet brands, industry experts and buyers. Jinglong’s successful participation not only confirms that the company fully meets international standards in terms of qualification, R&D, production and quality control, and possesses the strength to compete with outstanding global brands, but also builds an important bridge for communication and cooperation with international peers and overseas markets, helping the brand accurately grasp the development trends of the global pet industry.

Since its establishment, Wuhan Jinglong Biotechnology Co., Ltd. has strictly abided by international industry norms, and integrated compliant operation into the entire process of R&D, production, quality control and promotion of pet oral dispersible films. Focusing on this innovative dosage form, the company relies on high-quality domestic and international resources, adheres to scientific formulation principles, selects premium raw materials, and strictly controls raw material quality, striving to create safe, efficient and convenient new pet health care products. Its rigorous operation attitude and standardized management system have laid a solid foundation for this exhibition and international resource connection.

At the expo, Ms. Pan Zhihong, Chairwoman of Wuhan Jinglong Biotechnology, attended in person, explaining in detail the application scenarios, usage methods and core advantages of pet oral dispersible films to attendees, allowing everyone to intuitively experience the innovative value of the new product.

Covering key pet care scenarios including joint, intestinal and oral health, the products suit pets of all ages and physical conditions, directly addressing industry pain points of traditional pet supplements: difficult administration and slow absorption. The oral dispersible film dissolves rapidly upon contact with saliva, combining ready-to-use convenience and high absorption efficiency, along with excellent palatability. After on-site testing with real pets, the product’s advantages were fully validated, winning unanimous praise from exhibitors and merchants. It became a popular exhibit at the show, attracting numerous inquiries and intended collaborations, demonstrating strong market potential.

As an innovative biotechnology enterprise, Wuhan Jinglong Biotechnology has established a standardized production management system. It not only holds overseas export qualifications, but also is equipped with a Class 100,000 GMP clean workshop, modern production facilities and automated high-precision testing equipment.

The company has passed HACCP, ISO 22000 and cGMP certifications, and completed US FDA registration and review. With strict raw material selection, production control and finished product inspection mechanisms, it ensures stable product quality from the source — the core strength behind its recognition in overseas markets.

The successful conclusion of the Orlando Expo marks an important starting point for Wuhan Jinglong Biotechnology to enter the international market. Going forward, the company will take this exhibition as an opportunity to continuously optimize product formulations, refine core technologies, further deepen international cooperation and resource connectivity, empower the development of the pet care industry through innovation, and strive to become a key player in the global pet oral dispersible film sector.